PANAMA CITY, Nov. 19, 2025 (GLOBE NEWSWIRE) — Copa Holdings1, S.A. (NYSE: CPA), today announced financial results for the third quarter of 2025 (3Q25), delivering another quarter of strong profitability and operational excellence. Key highlights for the quarter include:Net profit of US$173.4 million or US$4.20 per share, compared to US$146.0 million or US$3.50 per share in 3Q24, representing year-over-year increases of 18.7% and 20.1%, respectively. Operating margin of 23.2% and net margin of 19.0%, an increase of 2.9 and 1.9 percentage points, respectively, compared to 3Q24. Load factor increased 1.8 percentage points year over year to 88.0% and capacity, measured in available-seat-miles (ASM), increased 5.8% compared to 3Q24. Revenue per available seat mile (RASM) of 11.1 cents, up 1.0% year-over-year. Operating cost per available...

OWINGS MILLS, Md., Nov. 19, 2025 (GLOBE NEWSWIRE) — Universal Safety Products, Inc. (NYSE AMEX: UUU) today announced results for its fiscal second quarter and six months ended September 30, 2025. For the three months ended September 30, 2025, sales decreased 89.4% to $759,999 compared to sales of $7,203,269 for the same period last year. The Company reported a net loss of $999,780, or $0.43 per basic and diluted share, compared to net income of $576,978 or $0.25 per basic and diluted share for the same period last year. For the six months ended September 30, 2025, sales decreased 61.2% to $4,584,246 versus $11,801,785 for the same period last year. The Company reported net income of $810,541, or $0.35 per basic share and $0.33 per diluted share, compared to net income of $134,772 or $0.06, per basic and diluted share for the corresponding...

Financial results highlighted by 78% sequential quarter over quarter revenue growth, showing the impact of the first full quarter of Sleep Center of Nevada operations Management to host conference call today at 5:00 pm ET to review results and provide operational updates LITTLETON, Colo., Nov. 19, 2025 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and healthcare services company specializing in the delivery of highly effective diagnostic procedures and proprietary treatments for sleep related breathing disorders (including all severities of obstructive sleep apnea (OSA) in adults and moderate to severe OSA in children), today reported financial results and operating highlights for the three and nine months ended September 30, 2025. Kirk Huntsman, Vivos’ Chairman...

NVIDIA corporate headquartersNVIDIA corporate headquarters in Silicon ValleyRecord revenue of $57.0 billion, up 22% from Q2 and up 62% from a year ago Record Data Center revenue of $51.2 billion, up 25% from Q2 and up 66% from a year agoSANTA CLARA, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) — NVIDIA (NASDAQ: NVDA) today reported record revenue for the third quarter ended October 26, 2025, of $57.0 billion, up 22% from the previous quarter and up 62% from a year ago. For the quarter, GAAP and non-GAAP gross margins were 73.4% and 73.6%, respectively. For the quarter, GAAP and non-GAAP earnings per diluted share were both $1.30. “Blackwell sales are off the charts, and cloud GPUs are sold out,” said Jensen Huang, founder and CEO of NVIDIA. “Compute demand keeps accelerating and compounding across training and inference...

ZyVersa is advancing a therapeutic development pipeline with multiple programs built around its two proprietary technologies – Cholesterol Efflux Mediator VAR 200 for treatment of kidney diseases, and Inflammasome ASC Inhibitor IC 100 for treatment of chronic inflammatory diseases. The lead indication for VAR 200 is focal segmental glomerulosclerosis (FSGS) with potential indication expansion in Alport syndrome and diabetic kidney disease. The lead indication for IC 100 is cardiometabolic conditions, with potential indication expansion in rare kidney diseases. Raised approximately $2.05 million in Q3-2025; $4.05 million year-to-date.WESTON, Fla., Nov. 19, 2025 (GLOBE NEWSWIRE) — ZyVersa Therapeutics, Inc. (OTCQB: ZVSA, or “ZyVersa”), a clinical-stage specialty biopharmaceutical company developing first-in-class drugs for treatment...

PRESS RELEASE Bloomberg (THEON:NA) / Reuters (THEON.AS)19 November 2025 – Theon Sensors SA, fully owned subsidiary of Theon International Plc (THEON) is pleased to announce that it has been officially invited by the Organisation for Joint Armament Cooperation (OCCAR), together with Hensoldt AG (HENSOLDT), to sign the first Contract Revision of its existing contract for the supply of additional advanced man-portable equipment. Pursuant to last week’s formal approval procedures by the two participating nations, Germany and Belgium, THEON and HENSOLDT will proceed with the official signing of the OCCAR Contract Revision on December 10, 2025, for the purchase of several thousand systems which are expected to materially increase THEON’s existing backlog. As per customary procedures, details of this Contract Revision will be announced...

Transaction Unlocks Shareholder Value and Refocuses Company on High-Growth AI, Cybersecurity, and Infrastructure Markets Conference Call to be Held Today at 10:00 am ET MELVILLE, N.Y., Nov. 19, 2025 (GLOBE NEWSWIRE) — Data Storage Corporation (Nasdaq: DTST) (the “Company”), today provided a business update and reported financial results for the three months and nine months ended September 30, 2025. Chuck Piluso, Chairman and Chief Executive Officer of Data Storage Corporation, commented, “This quarter represents a defining period for Data Storage Corporation as we completed the sale of our CloudFirst subsidiary and repositioned the Company for its next phase of disciplined growth. The CloudFirst sale was a transformative milestone that unlocked significant shareholder value and provided us with a solid financial foundation for...

MAYFIELD VILLAGE, OHIO, Nov. 19, 2025 (GLOBE NEWSWIRE) — The Progressive Corporation (NYSE:PGR) today reported the following results for the month ended October 31, 2025:  October(millions, except per share amounts and ratios; unaudited)   2025     2024     ChangeNet premiums written $         7,002   $         6,578             6   %Net premiums earned $         7,078   $         6,387             11   %Net income $         846   $         408             107   %Per share available to common shareholders $         1.44   $         0.69             107   %Total pretax net realized gains (losses) on securities $         57   $         (88 )           (165 ) %Combined ratio   89.7     94.1             (4.4 ) pts.Average diluted equivalent common shares   588.1     587.7     0   %    October 31,(thousands;...

Revenue of $104.3 million, processing revenue growth of 33% Organic Revenue growth of 25% (1) Net income of $3.5 million with Adjusted EBITDA of $18.2 million (1) Updates 2025 revenue and Adjusted EBITDA guidance to reflect delays in timing of M&As Reaffirming full year Organic Revenue growth guidance HERZLIYA, Israel, Nov. 19, 2025 (GLOBE NEWSWIRE) — Nayax Ltd. (Nasdaq: NYAX, TASE: NYAX), a global commerce payments and loyalty platform designed to help merchants scale their business, today announced its financial results for the third quarter ended September 30, 2025. “It was another strong quarter for Nayax, reflecting the continued execution of our strategy and our focus on profitable growth. We delivered strong operational and financial results, highlighted by expanding margins, disciplined growth across our segments,...

Third Quarter Highlights(All metrics compared to the third quarter of fiscal 2025)Record Contract Revenues of $1.452 billion, up 14.1% Record GAAP Diluted EPS of $3.63, up 35.4% compared to Q3 2025 Non-GAAP Diluted EPS Record Net Income of $106.4 million, up 34.4% compared to Q3 2025 Non-GAAP Net Income Record Adjusted EBITDA of $219.4 million, up 28.5% and representing 15.1% of contract revenues Strong Operating Cash Flows of $220.0 million Record Backlog of $8.2 billion as of October 25, 2025 Increasing Midpoint of Fiscal 2026 Revenue OutlookWEST PALM BEACH, Fla., Nov. 19, 2025 (GLOBE NEWSWIRE) — Dycom Industries, Inc. (NYSE: DY) announced today its results for the third quarter ended October 25, 2025. “We delivered an exceptional third quarter with record revenue, profitability and backlog, reinforcing our industry leadership...